3 High-Yield Dividend Stocks to Buy Hand Over Fist in June

Chevron is poised to pay attractive dividends regardless of what happens with oil prices.

Enterprise Products Partners offers an especially juicy yield, with a distribution that should continue to grow.

Rate cuts appear to be off the table for now due to surging inflation and a relatively strong jobs market. The current dynamics could drive increased market volatility, but they could also make dependable income more appealing to investors.

The good news is that there are plenty of stocks that offer attractive dividends and are good picks. Here are three high-yield dividend stocks to buy hand over fist in June.

Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »

AbbVie (NYSE: ABBV) markets 12 blockbuster drugs. Seven of them generate annual sales of over $2 billion, with autoimmune disease therapies Skyrizi and Rinvoq at the top of the list.

The pharma stock is a member of the Dividend Kings , a group limited only to stocks with at least 50 consecutive dividend increases. AbbVie's streak of dividend hikes now stands at 54 years, including the time it was part of Abbott Labs (NYSE: ABT) . Its dividend yield tops 3%.

Aside from its strong dividend, what makes AbbVie a great pick to buy in June? For one thing, the company is poised to deliver solid growth. AbbVie's product lineup includes at least a dozen drugs whose sales increased by double digits year over year in the latest quarter. The big drugmaker's pipeline also includes around 60 programs in mid- or late-stage clinical studies that could fuel additional growth in the coming years.